Misbranding Alert: What To Know About The Cookie Recall in Iowa, Minnesota, and 13 Other States

For decades, they've been a popular alternative to more traditional cookies like chocolate chip and oatmeal raisin, but a new product recall will make them a little harder to come by on some local store shelves.

The U.S. Food and Drug Administration (FDA) says nearly 6,000 cases of lemon cookies have been recalled.

5,826 cases of Soft Baked Iced Lemon Cookies from Lake Forest, Illinois-based Carley’s are impacted because of an apparent ingredient misidentification.

Why is there a recall?

According to the FDA report: 'Product has a misbranded Yellow Color. Identified on label [as] Artificial Yellow Color, and it should be identified as FD&C Yellow #5.'

FD&C Yellow #5, also known as 'tartrazine' or 'Yellow 5', is an artificial color additive that’s often found in food products like desserts, sodas, and cereals. While approved by the FDA, products containing Yellow 5 must clearly state the dye’s inclusion on product labels.

READ MORE: Sioux Falls' Cattitude Cafe Evolves With A Cozy Cat Interaction Space [PHOTOS]

How many cookies are included?

The recall of 5,826 cases means nearly 70,000 (69,912) cookies are impacted.

Where were the cookies sold?

According to Carley’s website, the cookies were sold to distributors that serve convenience stores, independent grocers, and small retail chains in Alabama, Georgia, Illinois, Iowa, Louisiana, Maryland, Michigan, Minnesota, New York, North Carolina, Pennsylvania, South Carolina, Texas, Virginia, and West Virginia.

Get our free mobile app

Recalled Product Information

• Carley’s Soft Baked Iced Lemon Cookies, 12 units per case
• 5.34 oz plastic tray, clear film overwrap with label
• Universal Product Code (UPC): 7 40235 50011 0
• Exp Date-Lot Code: 01726-040225, 11245-012825, 031026-051425, 061925-082324, 080525-100924, 081725-102124, 091025-111424, 061925-082324, 112425-012825

The FDA has classified the recall as a Class II event, which refers to 'use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.'